{
  "kind": "framework",
  "value": "bench-to-bedside",
  "collectionKey": "slides:framework:bench-to-bedside:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 1,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de073-8778-764b-accb-e5886cb9e840",
      "docSlug": "a27c0c380497fe380fc0ea99c606f1fe",
      "documentTitle": "Equillium | Results Presentation Deck | 32 slides",
      "authorId": "equillium",
      "authorName": "Equillium",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "other",
      "function": "illustrate_case",
      "notes": "The slide uses a 'Bench to Bedside' narrative structure to present scientific evidence.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "The slide title and structure explicitly follow the bench-to-bedside research progression model.",
      "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/12",
      "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840",
      "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-12",
      "loopMatches": [
        {
          "to": 31,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22",
          "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.",
          "position": 0,
          "objective": "What is the cost of not treating Lupus Nephritis effectively?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 30,
          "from": 10,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db",
          "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.",
          "position": 1,
          "objective": "What are the jobs to be done in treating Lupus Nephritis?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 31,
          "from": 10,
          "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}